Cite
HARVARD Citation
Vives, S. et al. (2021). A phase 3 trial of azacitidine versus a semi‐intensive fludarabine and cytarabine schedule in older patients with untreated acute myeloid leukemia. Cancer. 127 (12), pp. 2003-2014. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Vives, S. et al. (2021). A phase 3 trial of azacitidine versus a semi‐intensive fludarabine and cytarabine schedule in older patients with untreated acute myeloid leukemia. Cancer. 127 (12), pp. 2003-2014. [Online].